Alan Nurden: Platelet Defects Explain Bleeding in EHDS Patients
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared a post on LinkedIn about a recent article by Mariia Kumskova et al, published in Blood:
“While the Ehlers-Danlos syndrome (EHDS) is basically defined as a connective tissue disorder linked to increased elasticity many patients also report easy bruising and hemorrhagic problems. In this online paper in Blood, Mariia Kumskova and her colleagues describe how the platelet defects in EHDS patients are caused by decreased αIIbβ3 activation due to abnormally low talin-1 phosphorylation and a decreased presence of GPVI and PAR1, receptors for collagen and thrombin respectively.
As these signaling abnormalities were reproduced in a mouse (Col5a1+/-) model, it is therefore probable that the platelet defects directly explain the bleeding confirming that EHDS patients also have an inherited platelet disorder.
Interestingly, just as in Glanzmann thrombasthenia (where alphaIIbbeta3 function is absent), previous studies have shown that while thrombotic risk is reduced for EHDS patients, rare cases still occur and the general cardiovascular burden is not mitigated. An original and impressive study.”
Title: Platelet defects in patients and mice with Ehlers-Danlos syndrome
Authors: Mariia Kumskova, Gagan D Flora, Manasa K. Nayak, Ivan Budnik, Aditi Jain, Rakesh B. Patel, Abhishek B Jha, Madankumar Ghatge, Neelam Chauhan, James V. Michael, Steven E. McKenzie, Anjali Sharathkumar, Janice M Staber, Steven R Lentz, Anil Chauhan
Read the Full Article on Blood.

Other articles featuring Alan Nurden on Hemostasis Today.
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026